1/58
Vocabulary practice flashcards covering clinical nutrition, malabsorption, tissue integrity and wound care, neurocognition, pain physiology, and sleep medicine based on semester nursing lecture units.
Metabolic Syndrome (MetS)
A cluster of metabolic conditions diagnosed when an individual presents with at least 3 of 5 criteria: waist circumference ≥40 inches in men or ≥35 inches in women; fasting glucose ≥100mg/dL (or on medication); HDL cholesterol <40mg/dL in men or <50mg/dL in women; triglycerides ≥150mg/dL (or on medication); and blood pressure ≥130mmHg systolic or ≥85mmHg diastolic (or on antihypertensive treatment).
Failure to Thrive (Childhood)
A pediatric manifestation of undernutrition characterized by a Body Mass Index (BMI) below 5%.
Phytonadione (Vitamin K)
A fat-soluble vitamin administered via injection immediately after birth to prevent neonatal hemorrhage because newborn intestines cannot manufacture vitamin K until populated with bacteria; also utilized in adults to reverse hypoprothrombinemia and bleeding caused by warfarin toxicity.
Niacin Flush
A pharmacologic reaction occurring with high supplemental doses of nicotinic acid (Vitamin B3) characterized by cutaneous vasodilation and warmth, used clinically to decrease LDL and triglyceride levels while elevating HDL cholesterol.
Thick-it
A commercial xanthan gum or corn starch-based thickening agent added to liquids to modify viscosity for individuals experiencing dysphagia.
Aspiration
The misdirection of oropharyngeal secretions or gastric contents into the larynx and lower respiratory tract, occurring in approximately 40% to 50% of stroke clients with dysphagia and significantly increasing the risk for aspiration pneumonia.
Gastric Residual Volume (GRV)
The volume of aspirate obtained from an enteral feeding tube checked every 4 to 6 hours during continuous feedings and immediately before intermittent feedings; an order for a promotility agent is warranted when two or more consecutive measurements are ≥250mL.
Total Parenteral Nutrition (TPN)
A customized hypertonic intravenous solution administered via an infusion pump through a central venous catheter positioned in the superior vena cava to meet metabolic demands and prevent body protein catabolism when the gastrointestinal tract cannot be utilized.

Enteral Feeding Routes
Nutritional delivery methods directed into the gastrointestinal tract, including transnasal routes (nasogastric, nasoduodenal, and nasojejunal) and ostomy routes created surgically or endoscopically (esophagostomy, gastrostomy, and jejunostomy).

Celiac Disease (Gluten-Sensitive Enteropathy)
An autoimmune disorder triggered by ingestion of gluten (gliadin) from wheat, barley, and rye, culminating in T-cell-mediated villous atrophy, blunted mucosal surface area, osmotic and secretory diarrhea, and secondary nutrient malabsorption.
Dermatitis Herpetiformis (DH)
A pruritic, blistering cutaneous eruption typically localized over the elbows, knees, or buttocks that manifests as an extraintestinal complication of celiac disease.
Nephrotic Syndrome
A renal condition resulting from damaged glomerular basement membranes leading to massive proteinuria, hypovolemia, third-spacing edema, and an elevated risk of venous thrombosis due to the urinary loss of antithrombotic proteins.
Short Bowel Syndrome
A state of severe malabsorption and chronic diarrhea following substantial surgical resection of the small intestine, frequently requiring prolonged total parenteral nutrition until bowel compensation occurs.
Refeeding Syndrome
A metabolic instability occurring upon reintroducing carbohydrates to starved or severely malnourished patients, classically characterized by critical hypophosphatemia, cardiac dysrhythmias, and respiratory arrest.

Adaptive Feeding Equipment
Assistive dinnerware and silverware—including weighted utensils, wide built-up grips, universal utensil cuffs, plate guards, and double-handled mugs—designed to assist individuals with motor or neurological deficits during meal consumption.
Fibroblasts
The principal cellular components of the dermis responsible for synthesizing collagen and elastin, which confer tensile strength and resilience to skin tissue during wound repair.
Arterial (Ischemic) Ulcer
A lower extremity wound resulting from peripheral artery disease characterized by a deep, punched-out appearance with well-defined borders, pallor, cold extremities, and minimal wound exudate, managed by keeping limbs in a dependent position.
Venous Leg Ulcer
A lower extremity wound caused by chronic venous valve insufficiency and vascular pooling, typically located around the malleoli/ankles with irregular shallow margins, surrounding hyperpigmentation, and moderate to copious exudate, managed by elevation.
Granulation Tissue
Red, moist, vascularized viable connective tissue composed of newly generated capillary loops that proliferate in an open wound bed indicating healthy progression toward healing.
Slough
Soft, moist, stringy yellow or white nonviable devitalized fibrinous material adhering to the base of a wound bed that must be debrided before cellular reepithelialization can occur.
Eschar
Thick, leathery, black, brown, or dry necrotic devitalized tissue covering a wound bed that prevents accurate visual determination of wound depth until debrided.
Stage 1 Pressure Injury
A localized area of intact skin presenting with nonblanchable erythema over a bony prominence; dark-pigmented skin may present with changes in temperature, edema, firmness, or discoloration rather than observable blanching.
Stage 2 Pressure Injury
Partial-thickness skin loss characterized by an exposed, viable pink or red dermis, presenting as a moist, shallow open ulcer without slough or granulation, or as an intact or ruptured serum-filled blister.
Stage 3 Pressure Injury
Full-thickness tissue loss wherein subcutaneous adipose tissue is visible, but muscle, tendon, ligament, cartilage, and bone remain unexposed; epibole, undermining, and tunneling may be present.
Stage 4 Pressure Injury
Full-thickness skin and tissue loss with directly visible or palpable fascia, muscle, tendon, ligament, cartilage, or bone; slough, eschar, undermining, and tunneling are frequently present.
Unstageable Pressure Injury
Full-thickness skin and tissue loss in which the actual extent of tissue damage and depth of the wound base is entirely obscured by slough or eschar.
Deep Tissue Pressure Injury (DTPI)
Persistent, nonblanchable, localized deep red, maroon, or purple discoloration of intact or non-intact skin, or an epidermal separation resulting in a dark wound bed or blood-filled blister caused by intense shear and pressure at the bone-muscle interface.
Undermining
Tissue destruction and separation occurring underneath intact skin along the margins of a wound, creating a shelf-like pocket.
Tunneling
A narrow tract or passage extending from any portion of a wound bed into deeper underlying soft subcutaneous tissue.
Hydrocolloid Dressing
An occlusive or semi-occlusive adhesive wafer dressing composed of gel-forming polymers that maintains a moist environment and facilitates autolytic debridement in wounds with low to moderate exudate.
Calcium Alginate Dressing
A highly absorbent dressing derived from seaweed available in sheets or packing ropes that converts into a hydrophilic gel upon contact with drainage, designed specifically for wounds with heavy exudate.
Negative-Pressure Wound Therapy (NPWT)
A therapeutic modality utilizing a sealed vacuum dressing to deliver continuous or intermittent subatmospheric pressure, accelerating drainage evacuation, reducing interstitial edema, stimulating angiogenesis, and contracting wound margins.
Clear Liquid Diet
A diet consisting strictly of transparent liquids that leave minimal residue in the gastrointestinal tract (such as water, fat-free clear broth, black coffee, plain tea, gelatin, clear juices, and ice pops), indicated prior to colonoscopy or in acute GI illness.
Pureed Diet
A modified food texture diet consisting exclusively of smooth, pudding-like consistency items that contain no clumps or free thin liquids, prescribed for individuals with severe swallowing deficits or high aspiration risk.
Mechanical Soft Diet
A therapeutic diet comprising chopped, ground, mashed, or flaked foods requiring minimal mastication (such as ground meats, flaked fish, cottage cheese, eggs, and cooked soft vegetables), indicated for clients too weak to chew or recovering from head and neck surgery.
Renal Diet
A specialized diet designed to minimize buildup of metabolic wastes in impaired kidneys, restricted in sodium, phosphorus, and protein, with individualized restrictions on potassium and calcium based on serum lab parameters.

Cerebral Lobes
The distinct anatomical divisions of the cerebral cortex—frontal, parietal, temporal, and occipital lobes—supported by the diencephalon, cerebellum, and brainstem to regulate higher-order cognition, sensory integration, memory, and executive function.
Delirium
An acute, fluctuating cognitive disturbance marked by inattention, disorganized thinking, and altered level of consciousness, triggered by underlying physiological stressors (such as infections, drug toxicity, or metabolic derangements) and considered potentially reversible.
Dementia
A broad, progressive neurocognitive syndrome characterized by irreversible deterioration in multiple cognitive domains (such as memory, executive function, and orientation) that steadily compromises functional independence.
Amyloid Plaques
Extracellular clumps of insoluble protein fragments accumulating in synaptic spaces between neurons in Alzheimer disease, causing structural disruption of neuronal signal transmission.
Neurofibrillary Tangles
Intracellular twisted strands of abnormal tau protein inside neurons in Alzheimer disease that impair the microtubule transport system, resulting in cellular malfunction and apoptosis.
Aphasia
A cognitive impairment involving the partial or complete loss of language expression or verbal comprehension secondary to cortical dysfunction.
Apraxia
The inability to perform purposeful, skilled, previously learned motor acts despite possessing intact physical strength and sensory capacity.
Agnosia
The failure to recognize and identify familiar sensory stimuli, objects, sounds, or persons despite unimpaired primary sensory pathways.
Confabulation
The unconscious fabrication of stories or distorted facts to compensate for memory gaps without an intent to deceive, frequently observed in neurocognitive decline.
Sundowning
A clinical pattern seen in dementia wherein confusion, mood lability, motor restlessness, and agitation progressively exacerbate in the late afternoon and evening hours.
Donepezil (Aricept)
A centrally acting reversible cholinesterase inhibitor that slows enzymatic breakdown of acetylcholine in the synaptic cleft, used to palliate cognitive decline in mild to severe Alzheimer disease.
Memantine (Namenda)
An N-methyl-D-aspartate (NMDA) receptor antagonist that regulates glutamate activity and inhibits pathological influx of calcium into cortical neurons, preventing excitotoxicity in moderate-to-severe Alzheimer disease.
Transduction (Nociception)
The primary phase of pain signaling wherein noxious mechanical, thermal, or chemical stimuli cause tissue damage and trigger the release of sensitizing biochemicals (prostaglandins, bradykinin, serotonin, histamine, substance P) that activate peripheral nociceptors.
Neuropathic Pain
Pain generated by direct lesion, dysfunction, or disease affecting the somatosensory nervous system, characteristically described as burning, shooting, electric, or stabbing, often requiring adjuvant multimodal therapies.
Acute Pain
Pain with an anticipated duration of less than 3 months that subsides alongside normal tissue healing, accompanied by sympathetic activation signs including diaphoresis, tachycardia, tachypnea, and elevated blood pressure.
Chronic Pain
Pain persisting beyond normal tissue recovery time (typically greater than 3 months) that lacks protective sympathetic activation and instead presents with fatigue, apathy, flat affect, and social withdrawal.

Sleep Cycle Hypnogram
A graphical representation of the cyclical progression of human sleep spanning non-REM stages (N1, N2, N3/slow wave) and REM sleep occurring over approximately 90-minute intervals, with deep sleep dominant early in the night and REM episodes lengthening toward morning.
Slow-Wave Sleep (Stage N3)
Deep, restorative non-REM sleep characterized electroencephalographically by high-voltage delta waves, marked muscular relaxation, slow respirations, and high arousal thresholds, during which vital cellular repairs and growth hormone secretion take place.
Rapid Eye Movement (REM) Sleep
The sleep stage constituting approximately 20% to 25% of overall sleep distributed over 4 to 6 episodes, marked by rapid ocular movements, high cerebral metabolic activity, dreaming, and generalized somatic muscle atonia.
Obstructive Sleep Apnea (OSA)
A sleep-related breathing disorder marked by recurring transient collapse or occlusive obstruction of the upper pharyngeal airway during slumber, presenting highest risk in males, obese individuals, and clients with a neck circumference ≥16 inches.

Mallampati Score
A clinical classification grading system (Classes I through IV) assessing oropharyngeal anatomical structures visible on mouth opening to evaluate airway patency and predict the difficulty of intubation or risk of obstructive sleep apnea.
Polysomnography (PSG)
The definitive comprehensive multi-channel diagnostic recording performed during sleep to evaluate neurophysiological, respiratory, cardiac, and muscular variables across sleep stages.
Suvorexant (Belsomra)
A dual orexin receptor antagonist prescribed for insomnia that promotes sleep induction and maintenance by inhibiting the arousal-promoting neuropeptide transmitters orexin A and orexin B.